ConductScience.org, home

Gene · 64783

RBM15: RNA binding motif protein 15

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. RBM15: RNA binding motif protein 15. Genes, record 64783. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/64783

On this page

Gene

Symbol
RBM15
HGNC
Name
RNA binding motif protein 15
HGNC
NCBI Gene ID
64783
NCBI Gene
HGNC ID
HGNC:14959
HGNC
Ensembl
ENSG00000162775
NCBI Gene
Aliases
OTT, OTT1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q96T37RNA-binding protein 159772Ensembl, GeneID, HGNC

Source UniProt

Patents21

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1462381Q96T37Espacenet
EP 4650780 A22025-11-198669Q96T37Espacenet
EP 4641201 A22025-10-298859Q96T37Espacenet
JP 2025517969 A2025-06-128859Q96T37Espacenet
JP 2025517970 A2025-06-128669Q96T37Espacenet
US 12023371 B22024-07-024728Q96T37Espacenet
US 11446398 B22022-09-2075189Q96T37Espacenet
US 11446398 B22022-09-2075193Q96T37Espacenet
JP 2022524081 A2022-04-27178160Q96T37Espacenet
JP 2022524081 A2022-04-27178164Q96T37Espacenet

1 to 10 of 21

See all 21 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants743

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleRBM15 papersNewest fiscal year
P30CA021765Cancer Center Support Grant (CCSG)102025
ZIASC010357Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses72025
P30CA008748Cancer Center Support Grant62025
RM1HG008935Center for dynamic RNA epitranscriptomes - Renewal62025
P30CA016672Cancer Center Support Grant52025
ZIABC010334Conserved Element DNA Vaccine52025
R01CA186702Mechanisms of epitranscriptomic regulation in cancer42025
R01CA096512Cell model for KSHV infection and genetic manipulation32025
R01CA124332Regulation of KSHV replication by N6-methyladenosine (m6A)32025
R01CA271497The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia32025

1 to 10 of 743Source NIH's project files

See all 743 nih grants

Papers2,224

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
RNA m⁶A modification and its regulatory factors are altered in granulosa cells from women with PMOS.J Assist Reprod Genet202642687053PubTator, text miningPubMed
RBM15 in leukemogenesis: an emerging regulator at the interface of RNA biology and hematopoiesis.Trends Cancer202642680676PubTator, text miningPubMed
PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia.Leukemia202642637878PubTator, text miningPubMed
ZBTB33/RBM15 Axis Upregulates MACC1 to Promote the Malignant Progression of Colorectal Cancer.Curr Gene Ther202642634545PubTator, text miningPubMed
Integrative single-cell transcriptomic and epitranscriptomic analysis of the RBM15-m6A-IL10 regulatory axis in psoriatic keratinocytes.Front Cell Dev Biol202642614367PubTator, text miningPubMed
m6A-dependent regulation of DGUOK-AS1 by RBM15 and HNRNPH1 in lung adenocarcinoma.iScience202642603931PubTator, text miningPubMed
The N6-Methyladenosine-Modified CIT Promotes Uterine Corpus Endometrial Carcinoma Progression by Inhibiting the Hippo Signaling Pathway.Immunol Cell Biol202642565639PubTator, text miningPubMed
Global Phosphoproteome Analysis Identifies CLK4 Co-Regulatory Pathways Driving Tumor-Specific Dysregulation.OMICS202642484065PubTator, text miningPubMed
RBM15 plays a key driving role in the tumorigenesis of EGFR-mutant lung adenocarcinoma and gefitinib resistance.Sci Rep202642426119PubTator, text miningPubMed
RBM15 enhances ILDR1 n6-methyladenosine methylation to accelerate gastric adenocarcinoma progression via an IGF2BP3-dependent manner.Cytotechnology202642404851PubTator, text miningPubMed

1 to 10 of 2,224

See all 2,224 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/64783

GET https://conductscience.org/api/genes/v1/64783/patents?page=2